Real-world andexanet alfa utilization and the association between delay in administration due to hospital transfer and all-cause inpatient mortality by Huiqiao Fan, Youssef Bessada, Craig I. Coleman

Get full text

Novel anticoagulants for stroke prevention in atrial fibrillation: a systematic review of cost-effectiveness models. by Brendan L Limone, William L Baker, Jeffrey Kluger, Craig I Coleman

Get full text

Effectiveness, treatment durability, and treatment costs of canagliflozin and glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes in the USA by Mukul Singhal, Hiangkiat Tan, Craig I Coleman, Michelle Han, Chi Nguyen, Michael Ingham

Get full text

The Burden of Hospital Illness Associated with Disseminated Versus Isolated Pulmonary Coccidioidomycosis in the United States by Craig I. Coleman, Jessica Bylyku, Andria Latifi, Belinda Lovelace, Ryan Shan, Lahar Miriyapalli, Fariba Donovan

Get full text

Clinical and health care resource use burden of hospitalizations for oral factor Xa inhibitor‐associated major bleeding: A real‐world analysis of Medicare beneficiaries by James M. Williams, Belinda Lovelace, Mary J. Christoph, Suying Li, Haifeng Guo, Madison Hoover, Craig I. Coleman

Get full text

Specialist physician perspectives on non-medical switching of prescription medications by Olivia S. Costa, Tabassum Salam, Amy Duhig, Aarti A. Patel, Ann Cameron, Jennifer Voelker, Brahim Bookhart, Craig I. Coleman

Get full text

The impact of non-medical switching among ambulatory patients: an updated systematic literature review by Erin R. Weeda, Elaine Nguyen, Silas Martin, Michael Ingham, Diana M. Sobieraj, Brahim K. Bookhart, Craig I. Coleman

Get full text

Management of factor Xa inhibitor–related traumatic non‐intracranial bleeding events with andexanet alfa or four‐factor prothrombin complex concentrate in a US multicenter observat... by Paul P. Dobesh, Craig I. Coleman, Mark Danese, Eva Lesén, Raymond C. Chang, Onivefu Odelade, Gregory J. Fermann

Get full text

Predictors of Hospital Length of Stay among Patients with Low-risk Pulmonary Embolism by Li Wang, Onur Baser, Phil Wells, W. Frank Peacock, Craig I. Coleman, Gregory J. Fermann, Jeff Schein, Concetta Crivera

Get full text

Clinical and Economic Outcomes in Low-risk Pulmonary Embolism Patients Treated with Rivaroxaban versus Standard of Care by W. Frank Peacock, Craig I. Coleman, Phil Wells, Gregory J. Fermann, Li Wang, Onur Baser, Jeff Schein, Concetta Crivera

Get full text

Meta-analysis of real-world evidence comparing non-vitamin K antagonist oral anticoagulants with vitamin K antagonists for the treatment of patients with non-valvular atrial fibril... by Craig I. Coleman, Jean-Baptiste Briere, Laurent Fauchier, Pierre Levy, Kevin Bowrin, Mondher Toumi, Aurélie Millier, Vanessa Taieb, Olivia Wu

Get full text

Quality evaluation of case series describing four-factor prothrombin complex concentrate in oral factor Xa inhibitor-associated bleeding: a systematic review by Craig I Coleman, Olivia S Costa, William L Baker, Yuani Roman-Morillo, Kelly McNeil-Posey, Belinda Lovelace, C Michael White

Get full text

Real-World Antifungal Therapy Patterns Across the Continuum of Care in United States Adults with Invasive Aspergillosis by Barbara D. Alexander, Melissa Johnson, Mark Bresnik, Vamshi Ruthwik Anupindi, Lia Pizzicato, Mitchell DeKoven, Belinda Lovelace, Craig I. Coleman

Get full text

Comparative efficacy and safety of antidiabetic drug regimens added to metformin monotherapy in patients with type 2 diabetes: a network meta-analysis. by Elizabeth S Mearns, Diana M Sobieraj, C Michael White, Whitney J Saulsberry, Christine G Kohn, Yunes Doleh, Eric Zaccaro, Craig I Coleman

Get full text